Shandong Buchang Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
Shandong Buchang Pharmaceuticals has a total shareholder equity of CN¥10.8B and total debt of CN¥3.8B, which brings its debt-to-equity ratio to 35.4%. Its total assets and total liabilities are CN¥20.1B and CN¥9.3B respectively. Shandong Buchang Pharmaceuticals's EBIT is CN¥571.9M making its interest coverage ratio 5.4. It has cash and short-term investments of CN¥1.3B.
Key information
35.4%
Debt to equity ratio
CN¥3.82b
Debt
| Interest coverage ratio | 5.4x |
| Cash | CN¥1.31b |
| Equity | CN¥10.80b |
| Total liabilities | CN¥9.35b |
| Total assets | CN¥20.15b |
Recent financial health updates
Is Shandong Buchang Pharmaceuticals (SHSE:603858) Using Too Much Debt?
Jul 29
We Think Shandong Buchang Pharmaceuticals (SHSE:603858) Is Taking Some Risk With Its Debt
Feb 28Recent updates
The Market Doesn't Like What It Sees From Shandong Buchang Pharmaceuticals Co., Ltd.'s (SHSE:603858) Revenues Yet
Aug 26Is Shandong Buchang Pharmaceuticals (SHSE:603858) Using Too Much Debt?
Jul 29Why Investors Shouldn't Be Surprised By Shandong Buchang Pharmaceuticals Co., Ltd.'s (SHSE:603858) Low P/S
Apr 27We Think Shandong Buchang Pharmaceuticals (SHSE:603858) Is Taking Some Risk With Its Debt
Feb 28Financial Position Analysis
Short Term Liabilities: 603858's short term assets (CN¥7.6B) exceed its short term liabilities (CN¥6.1B).
Long Term Liabilities: 603858's short term assets (CN¥7.6B) exceed its long term liabilities (CN¥3.3B).
Debt to Equity History and Analysis
Debt Level: 603858's net debt to equity ratio (23.2%) is considered satisfactory.
Reducing Debt: 603858's debt to equity ratio has increased from 19.5% to 35.4% over the past 5 years.
Debt Coverage: 603858's debt is well covered by operating cash flow (24%).
Interest Coverage: 603858's interest payments on its debt are well covered by EBIT (5.4x coverage).